ResearchMoz

Pharmaceuticals and Healthcare Market Research Reports & Industry Analysis

The Pharmaceutical Industry is a key segment for global economical growth. While the industry is dominated ...

Pharmaceuticals and Healthcare

Sub Category

Browse reports in Pharmaceuticals and Healthcare

Displaying 2801 to 2830 (of 5433 records)
Pages: « Prev  89 90 91 92 93 94 95 96 97 98   Next »
Other Respiratory Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Other Respiratory Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Other Respiratory Disorders Pipeline Review, H2 2012', provides an overview of the Other Respiratory Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Respiratory Disorders, complete with latest updates, and special features on late-stage and...
$2000
Abortion - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Abortion Pipeline Review, H2 2012 Global Markets Directs, 'Abortion Pipeline Review, H2 2012', provides an overview of the Abortion therapeutic pipeline. This report provides information on the therapeutic development for Abortion, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Polycystic Ovarian Syndrome - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Polycystic Ovarian Syndrome Pipeline Review, H2 2012 Global Markets Directs, 'Polycystic Ovarian Syndrome Pipeline Review, H2 2012', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and...
$2000
Pancreatic Diseases - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Pancreatic Diseases Pipeline Review, H2 2012 Global Markets Directs, 'Pancreatic Diseases Pipeline Review, H2 2012', provides an overview of the Pancreatic Diseases therapeutic pipeline. This report provides information on the therapeutic development for Pancreatic Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Non- Rhabdomyosarcoma - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Non-Rhabdomyosarcoma Pipeline Review, H2 2012 Global Markets Directs, 'Non-Rhabdomyosarcoma Pipeline Review, H2 2012', provides an overview of the Non-Rhabdomyosarcoma therapeutic pipeline. This report provides information on the therapeutic development for Non-Rhabdomyosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Chikungunya - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Chikungunya Pipeline Review, H2 2012 Global Markets Directs, 'Chikungunya Pipeline Review, H2 2012', provides an overview of the Chikungunya therapeutic pipeline. This report provides information on the therapeutic development for Chikungunya, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Other Bacterial Infections - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Other Bacterial Infections Pipeline Review, H2 2012 Global Markets Directs, 'Other Bacterial Infections Pipeline Review, H2 2012', provides an overview of the Other Bacterial Infections therapeutic pipeline. This report provides information on the therapeutic development for Other Bacterial Infections, complete with latest updates, and special features on late-stage and...
$2000
Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Complicated Skin And Skin Structure Infections (cSSSI) Pipeline Review, H2 2012 Global Markets Directs, 'Complicated Skin And Skin Structure Infections (cSSSI) Pipeline Review, H2 2012', provides an overview of the Complicated Skin And Skin Structure Infections (cSSSI) therapeutic pipeline. This report provides information on the therapeutic development for Complicated Skin And...
$2000
Chronic Bronchitis - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Chronic Bronchitis Pipeline Review, H2 2012 Global Markets Directs, 'Chronic Bronchitis Pipeline Review, H2 2012', provides an overview of the Chronic Bronchitis therapeutic pipeline. This report provides information on the therapeutic development for Chronic Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews...
$2000
Angiosarcoma - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Angiosarcoma Pipeline Review, H2 2012 Global Markets Directs, 'Angiosarcoma Pipeline Review, H2 2012', provides an overview of the Angiosarcoma therapeutic pipeline. This report provides information on the therapeutic development for Angiosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in...
$2000
Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Metastatic Renal Cell Carcinoma Pipeline Review, H2 2012 Global Markets Directs, 'Metastatic Renal Cell Carcinoma Pipeline Review, H2 2012', provides an overview of the Metastatic Renal Cell Carcinoma therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with latest updates, and special features on...
$2000
Nausea - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Nausea Pipeline Review, H2 2012 Global Markets Directs, 'Nausea Pipeline Review, H2 2012', provides an overview of the Nausea therapeutic pipeline. This report provides information on the therapeutic development for Nausea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Inflammatory Pain - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Inflammatory Pain Pipeline Review, H2 2012 Global Markets Directs, 'Inflammatory Pain Pipeline Review, H2 2012', provides an overview of the Inflammatory Pain therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Streptococcal Infections - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Streptococcal Infections Pipeline Review, H2 2012 Global Markets Directs, 'Streptococcal Infections Pipeline Review, H2 2012', provides an overview of the Streptococcal Infections therapeutic pipeline. This report provides information on the therapeutic development for Streptococcal Infections, complete with latest updates, and special features on late-stage and discontinued...
$2000
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Plaque Psoriasis (Psoriasis Vulgaris) Pipeline Review, H2 2012 Global Markets Directs, 'Plaque Psoriasis (Psoriasis Vulgaris) Pipeline Review, H2 2012', provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) therapeutic pipeline. This report provides information on the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris), complete with latest updates, and...
$2000
Pollen Allergy - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Pollen Allergy Pipeline Review, H2 2012 Global Markets Directs, 'Pollen Allergy Pipeline Review, H2 2012', provides an overview of the Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic development for Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Other Musculoskeletal Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Other Musculoskeletal Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Other Musculoskeletal Disorders Pipeline Review, H2 2012', provides an overview of the Other Musculoskeletal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Musculoskeletal Disorders, complete with latest updates, and special features on...
$2000
Infections Caused By Picornaviridae - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Infections Caused By Picornaviridae Pipeline Review, H2 2012 Global Markets Directs, 'Infections Caused By Picornaviridae Pipeline Review, H2 2012', provides an overview of the Infections Caused By Picornaviridae therapeutic pipeline. This report provides information on the therapeutic development for Infections Caused By Picornaviridae, complete with latest updates, and special...
$2000
Inherited Metabolic Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Inherited Metabolic Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Inherited Metabolic Disorders Pipeline Review, H2 2012', provides an overview of the Inherited Metabolic Disorders therapeutic pipeline. This report provides information on the therapeutic development for Inherited Metabolic Disorders, complete with latest updates, and special features on late-stage...
$2000
Oral Cancer - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Oral Cancer Pipeline Review, H2 2012 Global Markets Directs, 'Oral Cancer Pipeline Review, H2 2012', provides an overview of the Oral Cancer therapeutic pipeline. This report provides information on the therapeutic development for Oral Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Lung Infections - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Lung Infections Pipeline Review, H2 2012 Global Markets Directs, 'Lung Infections Pipeline Review, H2 2012', provides an overview of the Lung Infections therapeutic pipeline. This report provides information on the therapeutic development for Lung Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Liver Transplantation - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Liver Transplantation Pipeline Review, H2 2012 Global Markets Directs, 'Liver Transplantation Pipeline Review, H2 2012', provides an overview of the Liver Transplantation therapeutic pipeline. This report provides information on the therapeutic development for Liver Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Pipeline Review, H2 2012 Global Markets Directs, 'Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Pipeline Review, H2 2012', provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) therapeutic pipeline. This report provides information on the therapeutic development for...
$2000
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Spinal Muscular Atrophy (SMA) Pipeline Review, H2 2012 Global Markets Directs, 'Spinal Muscular Atrophy (SMA) Pipeline Review, H2 2012', provides an overview of the Spinal Muscular Atrophy (SMA) therapeutic pipeline. This report provides information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with latest updates, and special features on late-stage...
$2000
Varicella Zoster (HHV- 3) Infections - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Varicella Zoster (HHV-3) Infections Pipeline Review, H2 2012 Global Markets Directs, 'Varicella Zoster (HHV-3) Infections Pipeline Review, H2 2012', provides an overview of the Varicella Zoster (HHV-3) Infections therapeutic pipeline. This report provides information on the therapeutic development for Varicella Zoster (HHV-3) Infections, complete with latest updates, and...
$2000
Enterococcus Faecium Infections - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Enterococcus Faecium Infections Pipeline Review, H2 2012 Global Markets Directs, 'Enterococcus Faecium Infections Pipeline Review, H2 2012', provides an overview of the Enterococcus Faecium Infections therapeutic pipeline. This report provides information on the therapeutic development for Enterococcus Faecium Infections, complete with latest updates, and special features on...
$2000
Measles - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Measles Pipeline Review, H2 2012 Global Markets Directs, 'Measles Pipeline Review, H2 2012', provides an overview of the Measles therapeutic pipeline. This report provides information on the therapeutic development for Measles, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic...
$2000
Lip Cancer - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Lip Cancer Pipeline Review, H2 2012 Global Markets Directs, 'Lip Cancer Pipeline Review, H2 2012', provides an overview of the Lip Cancer therapeutic pipeline. This report provides information on the therapeutic development for Lip Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Other Immunological Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Other Immunological Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Other Immunological Disorders Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Immunological Disorders, complete with latest updates, and special features on...
$2000
Other Psychiatric Disorders - Pipeline Review, H2 2012
Aug 2012   |   By - Global Markets Direct
Other Psychiatric Disorders Pipeline Review, H2 2012 Global Markets Directs, 'Other Psychiatric Disorders Pipeline Review, H2 2012', provides an overview of the Other Psychiatric Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Psychiatric Disorders, complete with latest updates, and special features on late-stage and...
$2000
 
Displaying 2801 to 2830 (of 5433 records)
Pages: « Prev  89 90 91 92 93 94 95 96 97 98   Next »